Skip to main content
Year archive

Infant Bacterial Therapeutics — 2021 filings

All 45 regulatory filings released by Infant Bacterial Therapeutics (IBT) in 2021, sourced directly from the official regulator.

45 Filings
2021 Period
2021 filings (45)
Filing Released Lang
Infant Bacterial Therapeutics tillkännager idag att nya patent har godkänts i Brasilien samt i Hong Kong
Regulatory Filings
2021-12-27 Swedish
Infant Bacterial Therapeutics today announces new patent protection approvals in Brazil and in Hong Kong
Regulatory Filings
2021-12-27 English
Infant Bacterial Therapeutics CFO leaves the company
Board/Management Information
2021-12-10 English
Infant Bacterial Therapeutics CFO lämnar bolaget
Board/Management Information
2021-12-10 Swedish
Major Shareholding Notification 2021
Major Shareholding Notification
2021-12-07 English
A Blinded Evaluation of the Connection Study – Sustained Feeding Tolerance (SFT) Correlates to Clinical Outcomes
Regulatory Filings
2021-12-06 English
EN BLINDAD UTVÄRDERING AV IBT:S CONNECTION STUDY – “SUSTAINED FEEDING TOLERANCE” (SFT) KORRELERAR MED KLINISKA UTFALL
Regulatory Filings
2021-12-06 Swedish
Nomination Committee appointed for the 2022 Annual General Meeting (AGM) in Infant Bacterial Therapeutics (IBT).
Board/Management Information
2021-10-29 English
Valberedning utsedd inför årsstämman 2022 i Infant Bacterial Therapeutics (IBT).
Board/Management Information
2021-10-29 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-10-29 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-10-29 English
IBT har uppnått ytterligare en milstolpe i sin fas III studie.
Regulatory Filings
2021-09-30 Swedish
Next recruitment milestone reached in IBT’s Phase III Study.
Regulatory Filings
2021-09-30 English
Efter säkerhetsgranskning har rekryteringen av de minsta barnen i the Connection study återupptagits.
Regulatory Filings
2021-09-22 Swedish
After safety review The Connection study is now again open to recruit the smallest infants.
Legal Proceedings Report
2021-09-22 English
Infant Bacterial Therapeutics today announces that a new patent is granted in Mexico
Regulatory Filings
2021-09-10 English
Infant Bacterial Therapeutics tillkännager idag att ett nytt patent har godkänts i Mexiko.
Legal Proceedings Report
2021-09-10 Swedish
Rekryteringen av de minsta barnen i the Connection study pausad
Environmental & Social Information
2021-08-25 Swedish
Recruitment of the smallest infants in the Connection study paused
Legal Proceedings Report
2021-08-25 English
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-08-13 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-08-13 English
Infant Bacterial Therapeutics AB appoints Marie-Louise Alamaa as new CFO
Board/Management Information
2021-07-13 English
Infant Bacterial Therapeutics AB utser Marie-Louise Alamaa till ny CFO
Board/Management Information
2021-07-13 Swedish
Infant Bacterial Therapeutics CFO lämnar bolaget
Board/Management Information
2021-05-20 Swedish
Infant Bacterial Therapeutics CFO leaves the company
Board/Management Information
2021-05-20 English
Annual General Meeting of Infant Bacterial Therapeutics CEO speech
Call Transcript
2021-05-06 English
VDs anförande i samband med Infant Bacterial Therapeutics årsstämma
Regulatory Filings
2021-05-06 Swedish
Årsstämma i Infant Bacterial Therapeutics
AGM Information
2021-05-04 Swedish
Annual General Meeting of Infant Bacterial Therapeutics
AGM Information
2021-05-04 English
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-05-04 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-05-04 English
Infant Bacterial Therapeutics expands The Connection Study to include infants with a birth weight below 750 grams
Regulatory Filings
2021-04-29 English
Infant Bacterial Therapeutics utökar The Connection Study och inkluderar spädbarn med en födelsevikt under 750 gram
Regulatory Filings
2021-04-29 Swedish
Infant Bacterial Therapeutics receives additional patent protection in China
Regulatory Filings
2021-04-15 English
Infant Bacterial Therapeutics erhåller ytterligare patentskydd i Kina
Regulatory Filings
2021-04-15 Swedish
Annual Report (ESEF) 2021
Annual Report (ESEF)
2021-04-09 Swedish
Annual Report (ESEF) 2021
Annual Report (ESEF)
2021-04-09 English
Kallelse till årsstämma i Infant Bacterial Therapeutics
AGM Information
2021-04-01 Swedish
Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics
AGM Information
2021-04-01 English
Infant Bacterial Therapeutics announces that the recruitment to the first stage of the Phase III Connection Study is completed - an update about the clinical development of IBP-9414
Legal Proceedings Report
2021-02-10 English
Infant Bacterial Therapeutics meddelar att rekryteringen till den första delen av fas III studien är klar - en uppdatering om den kliniska utvecklingen av IBP-9414
Regulatory Filings
2021-02-10 Swedish
Infant Bacterial Therapeutics today announces that new patent protection is granted in Japan
Regulatory Filings
2021-02-09 English
Infant Bacterial Therapeutics tillkännager idag att ett nytt patent har godkänts i Japan
Regulatory Filings
2021-02-09 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report FY 2020
2021-02-05 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report FY 2020
2021-02-05 English